2008
DOI: 10.4103/0377-4929.41676
|View full text |Cite
|
Sign up to set email alerts
|

Synovial hemangioma: A rare benign synovial lesion

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2011
2011
2021
2021

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 0 publications
0
4
0
Order By: Relevance
“…Pain is typically in the anterior aspect of the knee but can be posterior ( 14 ) or diffuse. Swelling, tenderness, effusion ( 5 , 9 11 , 17 , 21 , 23 , 26 , 30 , 33 , 34 , 44 , 49 , 50 , 55 ) and haemarthrosis ( 5 , 9 , 11 , 12 , 18 , 22 , 30 , 31 , 37 , 39 , 41 , 46 , 50 , 54 , 55 , 57 , 59 ) are frequent and can be recurrent. Occasionally, a palpable soft tissue mass ( 3 , 4 , 10 , 44 , 46 , 55 , 61 ) can be noted.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Pain is typically in the anterior aspect of the knee but can be posterior ( 14 ) or diffuse. Swelling, tenderness, effusion ( 5 , 9 11 , 17 , 21 , 23 , 26 , 30 , 33 , 34 , 44 , 49 , 50 , 55 ) and haemarthrosis ( 5 , 9 , 11 , 12 , 18 , 22 , 30 , 31 , 37 , 39 , 41 , 46 , 50 , 54 , 55 , 57 , 59 ) are frequent and can be recurrent. Occasionally, a palpable soft tissue mass ( 3 , 4 , 10 , 44 , 46 , 55 , 61 ) can be noted.…”
Section: Discussionmentioning
confidence: 99%
“…Anterior masses are more evident in complete flexion of the knee ( 3 , 21 , 44 ) and can be compressible, refilling when pressure is released ( 21 ). Limitation of motion ( 3 , 5 , 8 10 , 12 , 17 , 25 , 28 , 33 , 37 , 38 , 46 , 61 ) and mild muscular atrophy ( 5 , 11 , 33 , 34 , 36 , 49 , 55 ) can be present. Joint locking is infrequent but has been described when synovial haemangioma is located in the intercondylar notch ( 22 , 47 ) or in the suprapatellar pouch ( 6 ).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The management of IPEH/MH depends on the tumor size, extent, behavior, resectability, and the functional need of the individual [ 25 , 26 ]. They range from intrasynovial instillation of sclerosing agents (sodium tetradecyl sulfate [3% sterol], sodium morrhuate, monoethanolamine oleate, and sodium psylliate) [ 27 ], holmium ablation [ 28 ], Nd:YAG laser [ 29 ], cauterization [ 30 ], freezing [ 30 ], radiotherapy, embolization [ 30 ], and open or arthroscopic synovectomy [ 31 , 32 ].…”
Section: Discussionmentioning
confidence: 99%